Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing–remitting...

by Anthony Traboulsee, David K. B. Li, Mark Cascione, Juanzhi Fang, Fernando Dangond, Aaron Miller
Published 2018-09-01

Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory a...

by Anthony Traboulsee, David K. B. Li, Mark Cascione, Juanzhi Fang, Fernando Dangond, Aaron Miller
Published 2018-05-01

Phase IV study of retention on fingolimod injectable multiple sclerosis therapies: a randomized clinical trial

by Bruce A.C. Cree, Douglas L. Arnold, Mark Cascione, Edward J. Fox, Ian M. Williams, Xiangyi Meng, Lesley Schofield, Nadia Tenenbaum
Published 2018-05-01